Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 2/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25781205 | 0.92 | CYP4F2 (0.39) | MCL1CYP4F2CYP4A11NOTUMADRB2 | |
| SCHEMBL25771786 | 0.86 | OXER1 (0.38) | MCL1CYP4F2CYP4A11NOTUMADRB2 | |
| SCHEMBL25773868 | 0.82 | CCR5 (0.35) | MCL1CYP4F2CYP4A11NOTUMADRB2 | |
| SCHEMBL25772194 | 0.82 | RORC (0.38) | MCL1CYP4F2CYP4A11S1PR1S1PR5 | |
| SCHEMBL25781207 | 0.82 | CYP4F2 (0.37) | MCL1CYP4F2CYP4A11NOTUMADRB2 | |
| SCHEMBL25780755 | 0.80 | THRB (0.37) | ADRB2THRB | |
| SCHEMBL25771841 | 0.80 | OXER1 (0.40) | S1PR1S1PR5MEN1KMT2A | |
| SCHEMBL25778127 | 0.79 | ADRB3 (0.36) | MCL1NOTUMADRB2 | |
| SCHEMBL25780884 | 0.78 | OXER1 (0.51) | — | |
| SCHEMBL25780952 | 0.78 | OXER1 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023115203-A1 | OXER1 ANTAGONISTS AND USES THEREOF | FAIRHAVEN PHARMACEUTICALS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |